Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours.
about
Current and emerging therapies for advanced adrenocortical carcinoma.Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma.Molecular markers and targeted therapies for adrenocortical carcinoma.Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy.
P2860
Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Circulating vascular endotheli ...... patients with adrenal tumours.
@en
Circulating vascular endotheli ...... patients with adrenal tumours.
@nl
type
label
Circulating vascular endotheli ...... patients with adrenal tumours.
@en
Circulating vascular endotheli ...... patients with adrenal tumours.
@nl
prefLabel
Circulating vascular endotheli ...... patients with adrenal tumours.
@en
Circulating vascular endotheli ...... patients with adrenal tumours.
@nl
P2093
P356
P1476
Circulating vascular endotheli ...... patients with adrenal tumours
@en
P2093
Emil Nachev
Georgy Dashev
Georgy Kirilov
Iliana Atanassova
Maria Orbetzova
Radina Ivanova
Rositza Shigarminova
Sabina Zacharieva
P304
P356
10.1530/EJE.0.1500345
P577
2004-03-01T00:00:00Z